Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients.
Meredith IT, Dumonteil N, Blackman DJ, Tchétché D, Walters DL, Hildick-Smith D, Manoharan G, Harnek J, Worthley SG, Rioufol G, Lefèvre T, Modine T, Van Mieghem NM, Feldman T, Allocco DJ, Dawkins KD.
Meredith IT, et al. Among authors: dawkins kd.
EuroIntervention. 2017 Sep 20;13(7):788-795. doi: 10.4244/EIJ-D-16-01024.
EuroIntervention. 2017.
PMID: 28555592
Free article.